Atlas Trials

Safety and Efficacy of TrueTear™ for the Treatment of Meibomian Gland Disease

Clinical trial NCT03226769 · COMPLETED

Trial details

NCT number
NCT03226769
Sponsor
Allergan
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Meibomian GlandsDry Eye Syndromes
Start date
2017-07-26
Primary completion
2017-12-12
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.